Journal of Heart and Lung Transplantation

Papers
(The H4-Index of Journal of Heart and Lung Transplantation is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation587
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial 425
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients192
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant176
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing90
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass89
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System86
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation82
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy79
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients76
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil65
Early Onset Malignancy in the First-Year After Heart Transplantation62
Older Donor Hearts for Heart Transplantation59
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension58
WITHDRAWN58
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report56
Comparative Analysis of Fontan Transplant Outcomes56
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD54
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes54
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience53
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation51
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients50
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade48
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients48
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status47
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome47
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study47
Utility of Breath Volatomic Analysis in Lung Transplant Recipients45
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD44
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models44
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis43
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation42
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience41
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion41
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY40
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES40
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network38
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation37
0.038213968276978